Latest Breaking News On - American college of rheumatology convergence philip mease - Page 1 : comparemela.com

At 16 weeks, patients treated with bimekizumab reported greater improvements in both mean spine pain and morning stiffness when compared with placebo. These improvements continued through week 52.

San diegoUnited statesPhilip measeAmerican college of rheumatology convergence philip measeSwedish medical centerUniversity of washington school medicineAmerican college of rheumatologyRheumatology researchAmerican collegeRheumatology convergenceTreatment improved key patient reported symptomsAxial spondyloarthritis including spinal painMorning stiffnessWeek resultsTwo phaseWashington school